Johannesburg Declaration, A civil society declaration to UN Secretary- General High Level Panel on Access to Medicines highlights the factors that interlink system of financing biodmedical research, innovation and access to health technologies. It denounces the research funding that relies upon the grant of monopolies which eventually ‘produces to innovation gaps, inefficiencies, and distortions in the development of new health technologies’. The declaration clearly recommends ‘the costs of medical research and development should be delinked from the price of health technologies.’
- RCEP: India in a Catch-22
- Humira’s Best-Selling Drug Formula: Start at a High Price. Go Higher.
- Cancer Drug Price Rises 1, 400% With No Generic to Challenge It
- UACT statement regarding Chilean Congress resolution calling on the President to advance the compulsory licensing request on HCV drugs
- Justice Prabha Sridevan on Life, Laughter and IP